4.7 Article

A method for detecting epistasis in genome-wide studies using case-control multi-locus association analysis

Journal

BMC GENOMICS
Volume 9, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/1471-2164-9-360

Keywords

-

Funding

  1. Agencia IDEA
  2. Consejeria de Innovacion, Ciencia y Empresa [830882]
  3. Corporacion Tecnologica de Andalucia [07/124]
  4. Ministerio de Educacion y Ciencia [PCT-A41502790-2006, PCT-010000-2006-1]

Ask authors/readers for more resources

Background: The difficulty in elucidating the genetic basis of complex diseases roots in the many factors that can affect the development of a disease. Some of these genetic effects may interact in complex ways, proving undetectable by current single-locus methodology. Results: We have developed an analysis tool called Hypothesis Free Clinical Cloning (HFCC) to search for genome-wide epistasis in a case-control design. HFCC combines a relatively fast computing algorithm for genome-wide epistasis detection, with the flexibility to test a variety of different epistatic models in multi-locus combinations. HFCC has good power to detect multi-locus interactions simulated under a variety of genetic models and noise conditions. Most importantly, HFCC can accomplish exhaustive genome-wide epistasis search with large datasets as demonstrated with a 400,000 SNP set typed on a cohort of Parkinson's disease patients and controls. Conclusion: With the current availability of genetic studies with large numbers of individuals and genetic markers, HFCC can have a great impact in the identification of epistatic effects that escape the standard single-locus association analyses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

The Synergic Effect of AT(N) Profiles and Depression on the Risk of Conversion to Dementia in Patients with Mild Cognitive Impairment

Marta Marquie, Fernando Garcia-Gutierrez, Adelina Orellana, Laura Montrreal, Itziar de Rojas, Pablo Garcia-Gonzalez, Raquel Puerta, Claudia Olive, Amanda Cano, Isabel Hernandez, Maitee Rosende-Roca, Liliana Vargas, Juan Pablo Tartari, Ester Esteban-De Antonio, Urszula Bojaryn, Mario Ricciardi, Diana M. Ariton, Vanesa Pytel, Montserrat Alegret, Gemma Ortega, Ana Espinosa, Alba Perez-Cordon, Angela Sanabria, Nathalia Munoz, Nuria Lleonart, Nuria Aguilera, Ainhoa Garcia-Sanchez, Emilio Alarcon-Martin, Lluis Tarraga, Agustin Ruiz, Merce Boada, Sergi Valero

Summary: This study found that the association between Alzheimer's disease biomarkers and neuropsychiatric symptoms has a significant impact on the conversion to dementia in patients with mild cognitive impairment. A total of 500 individuals with MCI were followed-up yearly, and it was found that certain AT(N) profiles and the presence of depression and apathy were associated with a higher risk of conversion. The additive combination of AT(N) profile with depression exacerbates the risk of conversion, and a synergic effect of prodromal AD profile with depressive symptoms is evidenced.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Mendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer's Disease Aetiopathogenesis in Men

Pablo Garcia-Gonzalez, Itziar de Rojas, Sonia Moreno-Grau, Laura Montrreal, Raquel Puerta, Emilio Alarcon-Martin, Ines Quintela, Adela Orellana, Victor Andrade, Pamela V. Martino Adami, Stefanie Heilmann-Heimbach, Pilar Gomez-Garre, Maria Teresa Perinan, Ignacio Alvarez, Monica Diez-Fairen, Raul Nunez Llaves, Claudia Olive Roig, Guillermo Garcia-Ribas, Manuel Menendez-Gonzalez, Carmen Martinez, Miquel Aguilar, Mariateresa Buongiorno, Emilio Franco-Macias, Maria Eugenia Saez, Amanda Cano, Maria J. Bullido, Luis Miguel Real, Eloy Rodriguez-Rodriguez, Jose Luis Royo, Victoria Alvarez, Pau Pastor, Gerard Pinol-Ripoll, Pablo Mir, Miguel Calero Lara, Miguel Medina Padilla, Pascual Sanchez-Juan, Angel Carracedo, Sergi Valero, Isabel Hernandez, Lluis Tarraga, Alfredo Ramirez, Merce Boada, Agustin Ruiz

Summary: Mosaic loss of chromosome Y (mLOY) is a common somatic event associated with Alzheimer's disease (AD) and can be age-confounded in genome-wide association studies. This study used Mendelian randomisation to construct an age-independent mLOY polygenic risk score (mloy-PRS) and found that higher genetic risk for mLOY was associated with faster progression to AD in men with mild cognitive impairment. The study suggests that mLOY is involved in AD pathogenesis and shows associations with cerebrospinal fluid biomarkers.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Correlations between the NMR Lipoprotein Profile, APOE Genotype, and Cholesterol Efflux Capacity of Fasting Plasma from Cognitively Healthy Elderly Adults

Itziar de Rojas, Laura del Barrio, Isabel Hernandez, Laura Montrreal, Pablo Garcia-Gonzalez, Marta Marquie, Sergi Valero, Amanda Cano, Adelina Orellana, Merce Boada, Santos Manes, Agustin Ruiz

Summary: Cholesterol efflux capacity (CEC), which is closely related to Alzheimer's disease and other clinical conditions, is determined by APOE genotype and plasma metabolome profile. In this study, it was found that plasma 3-hydroxybutyrate and male sex were strongly correlated with CEC. Most NMR particles associated with CEC were not correlated with APOE genotype. The study confirmed the impact of APOE genotype on plasma lipoprotein particles and omega-3 fatty acids independently of plasma cholesterol level.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Infectious Diseases

Burden of significant liver damage in people living with HIV after microelimination of the hepatitis C virus

M. Santos, A. Corma-Gomez, M. Fernandez-Fuertes, A. Gonzalez-Serna, P. Rincon, L. M. Real, J. A. Pineda, J. Macias

Summary: This study investigated the prevalence and causes of significant liver damage among 619 people living with HIV. The results showed that 18.2% of the patients had significant liver damage, with 35.7% attributed to nonviral liver damage, mainly metabolic associated steatohepatitis. The study concluded that the burden of liver damage remains high among people living with HIV after HIV/HCV coinfection microelimination.

JOURNAL OF INFECTION (2023)

Article Neurosciences

Full protection from SARS-CoV-2 brain infection and damage in susceptible transgenic mice conferred by MVA-CoV2-S vaccine candidate

Javier Villadiego, Juan Garcia-Arriaza, Reposo Ramirez-Lorca, Roberto Garcia-Swinburn, Daniel Cabello-Rivera, Alicia E. Rosales-Nieves, Maria I. Alvarez-Vergara, Fernando Cala-Fernandez, Ernesto Garcia-Roldan, Juan L. Lopez-Ogayar, Carmen Zamora, David Astorgano, Guillermo Albericio, Patricia Perez, Ana M. Munoz-Cabello, Alberto Pascual, Mariano Esteban, Jose Lopez-Barneo, Juan Jose Toledo-Aral

Summary: In this study using a transgenic mouse model, it was found that SARS-CoV-2 primarily replicates in neurons in the brain, causing neuronal loss, glial activation, and vascular damage. However, vaccination with the MVA-CoV2-S vaccine provided full protection against cerebral infection and associated damage, even after reinfection.

NATURE NEUROSCIENCE (2023)

Review Pharmacology & Pharmacy

Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges

Amanda Cano, Alvaro Munoz-Morales, Elena Sanchez-Lopez, Miren Ettcheto, Eliana B. Souto, Antonio Camins, Merce Boada, Agustin Ruiz

Summary: Neurodegenerative diseases have unknown etiology in many cases and lack effective treatments. The blood-brain barrier poses a challenge for drug delivery. Exosomes, secreted vesicles, have emerged as promising therapeutic tools due to their natural origin and molecular similarities. They are particularly promising for targeting neurodegenerative diseases due to the difficulty of accessing the brain and the complexity of the diseases.

PHARMACEUTICS (2023)

Article Biochemistry & Molecular Biology

Aquaporin-4 Expression Switches from White to Gray Matter Regions during Postnatal Development of the Central Nervous System

Francisco Mayo, Lourdes Gonzalez-Vinceiro, Laura Hiraldo-Gonzalez, Claudia Calle-Castillejo, Sara Morales-Alvarez, Reposo Ramirez-Lorca, Miriam Echevarria

Summary: Aquaporin-4 (AQP4) is a water channel that is abundant in the central nervous system and plays a key role in maintaining water balance. While its expression and function in adults are well-established, little is known about its expression and localization during postnatal development. This study examined the expression of AQP4 mRNA and protein in the brain and spinal cord of mice at different stages of postnatal development. The results revealed changes in the expression and localization of AQP4 during early development, suggesting a potential role for AQP4 in early cell differentiation and myelination.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biotechnology & Applied Microbiology

Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment

Amanda Cano, Ester Esteban-de-Antonio, Mireia Bernuz, Raquel Puerta, Pablo Garcia-Gonzalez, Itziar de Rojas, Claudia Olive, Alba Perez-Cordon, Laura Montrreal, Raul Nunez-Llaves, Oscar Sotolongo-Grau, Emilio Alarcon-Martin, Sergi Valero, Montserrat Alegret, Elvira Martin, Pamela V. Martino-Adami, Miren Ettcheto, Antonio Camins, Assumpta Vivas, Marta Gomez-Chiari, Miguel angel Tejero, Adelina Orellana, Lluis Tarraga, Marta Marquie, Alfredo Ramirez, Merce Marti, Maria Isabel Pividori, Merce Boada, Agustin Ruiz

Summary: Alzheimer's disease (AD) is commonly preceded by a prodromal phase characterized by high levels of A beta and p-tau-mediated neuronal injury and mild cognitive impairment (MCI). Differential diagnosis of MCI causes in these prodromal stages is a challenge for clinicians. Blood biomarkers, particularly plasma extracellular vesicles (pEVs), are emerging as potential tools for early AD detection.

JOURNAL OF NANOBIOTECHNOLOGY (2023)

Article Neurosciences

Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer's disease in individuals with mild cognitive impairment: The NORFACE cohort

Marta Marquie, Ainhoa Garcia-Sanchez, Emilio Alarcon-Martin, Joan Martinez, Miguel Castilla-Marti, Luis Castilla-Marti, Adelina Orellana, Laura Montrreal, Itziar de Rojas, Pablo Garcia-Gonzalez, Raquel Puerta, Claudia Olive, Amanda Cano, Isabel Hernandez, Maitee Rosende-Roca, Liliana Vargas, Juan Pablo Tartari, Ester Esteban-De Antonio, Urszula Bojaryn, Mario Ricciardi, Diana M. Ariton, Vanesa Pytel, Montserrat Alegret, Gemma Ortega, Ana Espinosa, Alba Perez-Cordon, Angela Sanabria, Nathalia Munoz, Nuria Lleonart, Nuria Aguilera, Lluis Tarraga, Sergi Valero, Agustin Ruiz, Merce Boada

Summary: This study aimed to investigate the association between macular vessel density measured by optical coherence tomography angiography (OCT-A) and the AT(N) classification based on cerebrospinal fluid (CSF) biomarkers in individuals with mild cognitive impairment (MCI). The results showed that there was no association between macular vessel density measures and the AT(N) classification in MCI patients.

FRONTIERS IN NEUROSCIENCE (2023)

Article Medicine, General & Internal

Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease

Jiao Luo, Jesper Qvist Thomassen, Celine Bellenguez, Benjamin Grenier-Boley, Itziar de Rojas, Atahualpa Castillo, Kayenat Parveen, Fahri Kuecuekali, Aude Nicolas, Oliver Peters, Anja Schneider, Martin Dichgans, Dan Rujescu, Norbert Scherbaum, Deckert Juergen, Steffi Riedel-Heller, Lucrezia Hausner, Laura Molina Porcel, Emrah Duezel, Timo Grimmer, Jens Wiltfang, Stefanie Heilmann-Heimbach, Susanne Moebus, Thomas Tegos, Nikolaos Scarmeas, Jordi Clarimon, Fermin Moreno, Jordi Perez-Tur, Maria J. Bullido, Pau Pastor, Raquel Sanchez-Valle, Victoria Alvarez, Merce Boada, Pablo Garcia-Gonzalez, Raquel Puerta, Pablo Mir, Luis M. Real, Gerard Pinol-Ripoll, Jose Maria Garcia-Alberca, Jose Luis Royo, Eloy Rodriguez-Rodriguez, Hilkka Soininen, Teemu Kuulasmaa, Alexandre de Mendonca, Shima Mehrabian, Jakub Hort, Martin Vyhnalek, Sven van der Lee, Caroline Graff, Goran Papenberg, Vilmantas Giedraitis, Anne Boland, Delphine Bacq-Daian, Jean-Francois Deleuze, Gael Nicolas, Carole Dufouil, Florence Pasquier, Olivier Hanon, Stephanie Debette, Edna Gruenblatt, Julius Popp, Luisa Benussi, Daniela Galimberti, Beatrice Arosio, Patrizia Mecocci, Vincenzo Solfrizzi, Lucilla Parnetti, Alessio Squassina, Lucio Tremolizzo, Barbara Borroni, Benedetta Nacmias, Sandro Sorbi, Paolo Caffarra, Davide Seripa, Innocenzo Rainero, Antonio Daniele, Carlo Masullo, Gianfranco Spalletta, Julie Williams, Philippe Amouyel, Frank Jessen, Patrick Kehoe, Tsolaki Magda, Giacomina Rossi, Pascual Sanchez-Juan, Kristel Sleegers, Martin Ingelsson, Ole A. Andreassen, Mikko Hiltunen, Cornelia Van Duijn, Rebecca Sims, Wiesje van der Flier, Agustin Ruiz, Alfredo Ramirez, Jean-Charles Lambert, Ruth Frikke-Schmidt

Summary: This genetic association study identifies novel genetic associations between high HDL cholesterol concentrations and high systolic blood pressure with increased risk of AD, potentially inspiring new drug targeting and improved prevention implementation.

JAMA NETWORK OPEN (2023)

Article Medicine, General & Internal

Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

Javier Martinez-Sanz, Jorge Diaz-alvarez, Marta Rosas, Raquel Ron, Jose Antonio Iribarren, Enrique Bernal, Felix Gutierrez, Andres Ruiz Sancho, Noemi Cabello, Julian Olalla, Santiago Moreno, Sergio Serrano-Villar

Summary: The study suggests that a low CD4/CD8 ratio during HIV treatment is associated with immunosenescence. Data analysis shows that patients with a CD4/CD8 ratio less than 0.3 in the second year of ART have an increased risk of developing SNAEs in the next five years.

EBIOMEDICINE (2023)

Article Multidisciplinary Sciences

A metagenome-wide association study of HIV disease progression in HIV controllers

Luis Miguel Real, Maria E. Saez, Anais Corma-Gomez, Antonio Gonzalez-Perez, Christian Thorball, Rocio Ruiz, Maria Reyes Jimenez-Leon, Alejandro Gonzalez-Serna, Carmen Gasca-Capote, Maria Jose Bravo, Jose Luis Royo, Alberto Perez-Gomez, Maria Ines Camacho-Sojo, Isabel Gallego, Joana Vitalle, Sara Bachiller, Alicia Gutierrez-Valencia, Francisco Vidal, Jacques Fellay, Mathias Lichterfeld, Ezequiel Ruiz-Mateos, Swiss HIV Cohort Study

Summary: Some HIV controllers experience immunologic progression with CD4(+) T cell decline. Genetic factors associated with CD4(+) T cell decline in HIV controllers were identified. Specific genetic factors were found to be associated with the long-term non-progressor HIV spontaneous control phenotype.

ISCIENCE (2023)

No Data Available